FDA Approves Unknown Drug — IVAX SUB TEVA PHARMS

IVAX SUB TEVA PHARMS received FDA approval for ANDA076089 on June 9, 2004, paving the way for the launch of a new generic drug that barring patent challenges is expected to capitalize on an imminent U.S. market vacuum.